Abstract
Objective The minor allele of rs373863828 in CREBRF is associated with higher BMI, lower fasting glucose, and lower odds of type 2 diabetes. We examined the associations between BMI and rs373863828 on type 2 diabetes and fasting glucose with a large sample of adult Polynesians from Samoa, American Samoa and Aotearoa New Zealand and estimated direct and indirect (via BMI) effects of rs373863828 on type 2 diabetes and fasting glucose.
Research Design and Methods We regressed type 2 diabetes and fasting glucose on BMI and rs373863828 stratified by obesity, regressed type 2 diabetes and fasting glucose on BMI stratified by rs373863828 genotype, and assessed the effects of rs373863828 on type 2 diabetes and fasting glucose with path analysis.
Results Association of BMI with fasting glucose was greater in those without obesity than in those with obesity. We did not observe evidence of differences by genotype. In the path analysis, the minor allele has direct negative and indirect positive effects on type 2 diabetes risk and fasting glucose, with the indirect effect mediated through a direct positive effect on BMI.
Conclusions There may be a stronger effect of BMI on fasting glucose in Polynesians without obesity than in those with obesity. Carrying the rs373863828 minor allele does not decouple higher BMI from odds of type 2 diabetes. Given the current cost of genotyping compared to the accessibility of measuring BMI, including rs373863828 as a clinical predictor of type 2 diabetes may not be indicated.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research in Samoa and American Samoa was funded by the National Institute of Health (R01-HL093093, R01-HL133040, R01-AG09375, R01-HL52611, R01-DK55406, P30-ES006096, and R01-DK59642). Research in New Zealand was funded by the Health Research Council of New Zealand (08/075, 10/548, 11/1075, 14/527).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All participants in these studies gave written informed consent. The research in Samoa and American Samoa was reviewed and approved by the institutional review boards of Miriam Hospital, Providence, RI; Brown University; University of Cincinnati; and University of Pittsburgh. Research in Samoa was also reviewed and approved by the Health Research Committee of the Samoan Ministry of Health. Research in American Samoa was additionally reviewed and approved by the American Samoa Department of Health institutional review board. Ethical approval for the Aotearoa New Zealand study was given by the NZ Multi-Region Ethics Committee (MEC/05/10/130; MEC/10/09/092; MEC/11/04/036) and the Northern Y Region Health Research Ethics Committee (NPHCT study; NTY07/07/074).
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The 2010 sample data from Samoa examined in this study are available from dbGaP (accession number: phs000914.v1.p1). The 1991-95 and 2002-03 sample data from Samoa and American Samoa is not available because participants did not consent to data sharing when enrolled. Sample data from Aotearoa New Zealand is not publicly available owing to consent restrictions but can be requested from author TRM under an appropriate arrangement.
Abbreviations
- cAge
- mean-centered scaled age
- cAge2
- mean-centered scaled age squared
- CREBRF
- cAMP-responsive element binding protein 3 regulatory factor
- lnBMI
- natural logarithm of BMI
- lnFG
- natural logarithm of fasting blood glucose
- MAF
- minor allele frequency
- OR
- odds ratio
- RMSEA
- root mean square error of approximation